These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 33197439)
21. [Expression and Clinical Significance of CXCR3 in Mantle Cell Lymphoma]. Zhu MX; Wan WL; Hong Y; Zhu XW; Hu K; Wan W; Jing HM; Ke XY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):1831-1837. PubMed ID: 31839046 [TBL] [Abstract][Full Text] [Related]
22. An alternatively spliced variant of CXCR3 mediates the metastasis of CD133+ liver cancer cells induced by CXCL9. Ding Q; Xia Y; Ding S; Lu P; Sun L; Liu M Oncotarget; 2016 Mar; 7(12):14405-14. PubMed ID: 26883105 [TBL] [Abstract][Full Text] [Related]
23. Infiltration of Th1 and Th2 lymphocytes around Hodgkin and Reed-Sternberg (H&RS) cells in Hodgkin disease: Relation with expression of CXC and CC chemokines on H&RS cells. Ohshima K; Tutiya T; Yamaguchi T; Suzuki K; Suzumiya J; Kawasaki C; Haraoka S; Kikuchi M Int J Cancer; 2002 Apr; 98(4):567-72. PubMed ID: 11920617 [TBL] [Abstract][Full Text] [Related]
24. Identification of the SRC-family tyrosine kinase HCK as a therapeutic target in mantle cell lymphoma. Lantermans HC; Minderman M; Kuil A; Kersten MJ; Pals ST; Spaargaren M Leukemia; 2021 Mar; 35(3):881-886. PubMed ID: 32591642 [TBL] [Abstract][Full Text] [Related]
25. The CXC chemokine murine monokine induced by IFN-gamma (CXC chemokine ligand 9) is made by APCs, targets lymphocytes including activated B cells, and supports antibody responses to a bacterial pathogen in vivo. Park MK; Amichay D; Love P; Wick E; Liao F; Grinberg A; Rabin RL; Zhang HH; Gebeyehu S; Wright TM; Iwasaki A; Weng Y; DeMartino JA; Elkins KL; Farber JM J Immunol; 2002 Aug; 169(3):1433-43. PubMed ID: 12133969 [TBL] [Abstract][Full Text] [Related]
26. Sarcoidosis and the alpha chemokine MIG. Giusti C Clin Ter; 2020; 171(2):e161-e166. PubMed ID: 32141489 [TBL] [Abstract][Full Text] [Related]
27. [Effects of the phosphoinostitide-3'-kinase delta inhibitor, CAL-101, in combination with Bortezomib on mantle lymophma cells and exploration of its related mechanism]. Qu F; Xia B; Li X; Guo S; Zhang L; Tian C; Yu Y; Zhang Y Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):412-7. PubMed ID: 26463142 [TBL] [Abstract][Full Text] [Related]
29. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome. Ogawa N; Ping L; Zhenjun L; Takada Y; Sugai S Arthritis Rheum; 2002 Oct; 46(10):2730-41. PubMed ID: 12384933 [TBL] [Abstract][Full Text] [Related]
30. CXCR3-positive B cells found at elevated frequency in the peripheral blood of patients with MALT lymphoma are attracted by MIG and belong to the lymphoma clone. Suefuji H; Ohshima K; Karube K; Kawano R; Nabeshima K; Suzumiya J; Hayabuchi N; Kikuchi M Int J Cancer; 2005 May; 114(6):896-901. PubMed ID: 15645433 [TBL] [Abstract][Full Text] [Related]
31. MicroRNA-506 inhibits the proliferation and invasion of mantle cell lymphoma cells by targeting B7H3. Zhu XW; Wang J; Zhu MX; Wang YF; Yang SY; Ke XY Biochem Biophys Res Commun; 2019 Jan; 508(4):1067-1073. PubMed ID: 30553455 [TBL] [Abstract][Full Text] [Related]
32. Abundant expression of CXCL9 (MIG) by stromal cells that include dendritic cells and accumulation of CXCR3+ T cells in lymphocyte-rich gastric carcinoma. Ohtani H; Jin Z; Takegawa S; Nakayama T; Yoshie O J Pathol; 2009 Jan; 217(1):21-31. PubMed ID: 18980207 [TBL] [Abstract][Full Text] [Related]
33. Krüppel-like factor 4 contributes to the pathogenesis of mantle cell lymphoma. Li XY; Geng LY; Zhou XX; Wei N; Fang XS; Li Y; Wang X Leuk Lymphoma; 2017 Oct; 58(10):2460-2469. PubMed ID: 28278702 [TBL] [Abstract][Full Text] [Related]
34. Oral cancer-associated fibroblasts inhibit heat-induced apoptosis in Tca8113 cells through upregulated expression of Bcl-2 through the Mig/CXCR3 axis. Bian L; Sun X; Jin K; He Y Oncol Rep; 2012 Dec; 28(6):2063-8. PubMed ID: 22961626 [TBL] [Abstract][Full Text] [Related]
35. B7-H3 silencing inhibits tumor progression of mantle cell lymphoma and enhances chemosensitivity. Zhang W; Wang Y; Wang J; Dong F; Zhu M; Wan W; Li H; Wu F; Yan X; Ke X Int J Oncol; 2015; 46(6):2562-72. PubMed ID: 25872657 [TBL] [Abstract][Full Text] [Related]
36. Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3+ lymphocytes. García-López MA; Sancho D; Sánchez-Madrid F; Marazuela M J Clin Endocrinol Metab; 2001 Oct; 86(10):5008-16. PubMed ID: 11600578 [TBL] [Abstract][Full Text] [Related]
37. MiR-132-3p serves as a tumor suppressor in mantle cell lymphoma via directly targeting SOX11. Wu B; Li J; Wang H; Wu Q; Liu H Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2197-2208. PubMed ID: 32040593 [TBL] [Abstract][Full Text] [Related]
38. Novel role of the CXC chemokine receptor 3 in inflammatory response to arterial injury: involvement of mTORC1. Schwarz JB; Langwieser N; Langwieser NN; Bek MJ; Seidl S; Eckstein HH; Lu B; Schömig A; Pavenstädt H; Zohlnhöfer D Circ Res; 2009 Jan; 104(2):189-200. PubMed ID: 19059841 [TBL] [Abstract][Full Text] [Related]
39. IL-4 enhances keratinocyte expression of CXCR3 agonistic chemokines. Albanesi C; Scarponi C; Sebastiani S; Cavani A; Federici M; De Pità O; Puddu P; Girolomoni G J Immunol; 2000 Aug; 165(3):1395-402. PubMed ID: 10903743 [TBL] [Abstract][Full Text] [Related]
40. The chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes by the chemokines IP10 and Mig. Piali L; Weber C; LaRosa G; Mackay CR; Springer TA; Clark-Lewis I; Moser B Eur J Immunol; 1998 Mar; 28(3):961-72. PubMed ID: 9541591 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]